GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Petlife Pharmaceuticals Inc (OTCPK:PTLF) » Definitions » PB Ratio

Petlife Pharmaceuticals (Petlife Pharmaceuticals) PB Ratio : (As of May. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Petlife Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-28), Petlife Pharmaceuticals's share price is $0.0001. Petlife Pharmaceuticals's Book Value per Share for the quarter that ended in Feb. 2018 was $-0.03. Hence, Petlife Pharmaceuticals's PB Ratio of today is .

The historical rank and industry rank for Petlife Pharmaceuticals's PB Ratio or its related term are showing as below:

PTLF's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.97
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Petlife Pharmaceuticals PB Ratio Historical Data

The historical data trend for Petlife Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Petlife Pharmaceuticals PB Ratio Chart

Petlife Pharmaceuticals Annual Data
Trend Aug08 Aug09 Aug10 Aug11 Aug12 Aug13 Aug14 Aug15 Aug16 Aug17
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 3,125.00 - - -

Petlife Pharmaceuticals Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Petlife Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Petlife Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Petlife Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Petlife Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Petlife Pharmaceuticals's PB Ratio falls into.



Petlife Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Petlife Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Feb. 2018)
=0.0001/-0.025
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Petlife Pharmaceuticals  (OTCPK:PTLF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Petlife Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Petlife Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Petlife Pharmaceuticals (Petlife Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.
Executives
Randy Steven White director, 10 percent owner, officer: President/Secretary/Treasurer OPLETALOVA 43, PRAGUE 2N 11000

Petlife Pharmaceuticals (Petlife Pharmaceuticals) Headlines